Please note that we have stopped the regular imports of Gene Expression Omnibus (GEO) data into ArrayExpress. This may not be the latest version of this experiment.

E-GEOD-20597 - Gene expression profile of STAT3 in ovarian cancer cell (SKOV3ip1)

Released on 22 December 2011, last updated on 4 January 2012
Homo sapiens
Samples (6)
Array (1)
Protocols (7)
RNA interference (RNAi) holds tremendous potential as a therapeutic approach, especially in the treatment of malignant tumors. However, efficient and biocompatible delivery methods are needed for systemic delivery of siRNA. To achieve this goal, we have established a novel formulation of siRNA by incorporating it into reconstituted high density lipoprotein (rHDL) nanoparticles. Here, we demonstrate that rHDL nanoparticles facilitate highly efficient systemic delivery of siRNA in vivo, mediated by the scavenger receptor type B1 (SR-B1). Moreover, in therapeutic proof-of-concept studies, these nanoparticles were effective in targeting either signal transducer and activator of transcription 3 (STAT3) or focal adhesion kinase (FAK) expression in orthotopic mouse models of ovarian and colorectal cancer. These data indicate that an rHDL nanoparticle is a novel and highly efficient siRNA carrier, and therefore this novel technology could serve as the foundation for new cancer therapeutic approaches. To identify the role of STAT3 in ovarian cancer cell, we performed microarray after knocking down STAT3 in ovarican cancer cells (3 siCon and 3 siSTAT3).
Experiment type
transcription profiling by array 
Sangbae Kim <>, Anil K Sood, Ju-seog Lee, Mian M Shahzad, Yun-Yong Park
Investigation descriptionE-GEOD-20597.idf.txt
Sample and data relationshipE-GEOD-20597.sdrf.txt
Processed data (1)
Array designA-MEXP-1171.adf.txt